Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Achieve Life Sciences › Alyeska Investment Group, L.P. cut its ACHV stake below 5% (3.2%) Fund moves
Why it stands out The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Sep 30, 2026
Reporting period Not applicable
Filed with the SEC Nov 16, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001172661-26-005358
Data quality Verified: identifiers matched exactly
Around the same time Insider filing
Traded Oct 5 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Oct 5 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Aug 11, 2026 Company filing · Form 8-K · Results Reported its results What came next Oct 1, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On October 1, 2026, Achieve Life Sciences, Inc. (the “ Company ”) announced that the Board of Directors of the Company (the “ Board ”) appointed Benjamin Halladay as the Company’s Chief Financial Officer and “principal financial officer,” effective as of October 5, 2026 (the “ Appointment Date ”).” Nov 10, 2026 Company filing · Form 8-K · Results Reported its results Nov 16, 2026 5% stake Logos Global Management LP reported a passive stake (13G) of 8.6% Nov 16, 2026 5% stake Logos Global Management LP reported a passive stake (13G) of 10.0% Nov 16, 2026 5% stake Alyeska Investment Group, L.P. reported a passive stake (13G) of 3.2% Nov 16, 2026 5% stake Venrock Healthcare Capital Partners III, L.P. reported a passive stake (13G) of 5.2%